Načítá se...
IRX-2, a novel biologic, favors the expansion of T effector over T regulatory cells in a human tumor microenvironment model
IRX-2, a natural cytokine biological with multiple components, has been used in preclinical and clinical studies to promote antitumor activity of T lymphocytes. To define cellular mechanisms responsible for antitumor effects of IRX-2, its ability to induce effector T cells (Teff) was examined in a m...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer-Verlag
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3268969/ https://ncbi.nlm.nih.gov/pubmed/21915712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00109-011-0813-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|